Search for 'an,phr: 303' with limit(s): 'itype:REV'

Current Challenges in Cancer Treatment.

By Zugazagoitia, Jon | Guedes, Cristiano | Ponce Aix, Santiago | Ferrer, Irene | Molina Pinelo, Sonia | Paz-Ares Rodríguez, Luis. Clinical therapeutics, 2016 . 38(7):1551-66. , Formato Vancouver: Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina Pinelo S, Paz Ares L. Current Challenges in Cancer Treatment. Clin Ther. 2016 Jul;38(7):1551-66.

Place Hold on Current Challenges in Cancer Treatment.

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

By Rojas Laimito, Katerin | Sepúlveda Sánchez, Juan Manuel | Manso Sánchez, Luis | Pascual, Tomás | Ciruelos Gil, Eva María. Ecancermedicalscience, 2016 . 10:632. , Formato Vancouver: Laimito KR, Gámez Pozo A, Sepúlveda J, Manso L, López Vacas R, Pascual T et al. Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases. Ecancermedicalscience. 2016 Apr 11;10:632.

Place Hold on Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.

By García Carbonero, Rocío . Cancer metastasis reviews, 2015 . 34(4):823-42. , Formato Vancouver: García Carbonero R, García Figueiras R, Carmona Bayonas A, Sevilla I, Teule A, Quindos M et al; Spanish Cooperative Group of Neuroendocrine Tumors (GETNE). Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development. Cancer Metastasis Rev. 2015 Dec;34(4):823-42.

Place Hold on Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development.

Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.

By Castellano, Daniel. Cancer chemotherapy and pharmacology, 2015 . 75(6):1099-114. , Formato Vancouver: Castellano D, Grande E, Valle J, Capdevila J, Reidy Lagunes D, O'Connor JM et al. Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors. Cancer Chemother Pharmacol. 2015 Jun;75(6):1099-114.

Place Hold on Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.

El receptor del factor de crecimiento epidérmico (EGFR) en el glioblastoma: mecanismo de tumorigénesis y papel como diana terapéutica.

By Sepúlveda Sánchez, Juan Manuel. Revista de neurología, 2015 . 61(2):85-93. , Formato Vancouver: Zahonero C, Sepúlveda JM, Sánchez Gómez P. El receptor del factor de crecimiento epidérmico (EGFR) en el glioblastoma: mecanismo de tumorigénesis y papel como diana terapéutica. Rev Neurol. 2015 Jul 16;61(2):85-93.

Place Hold on El receptor del factor de crecimiento epidérmico (EGFR) en el glioblastoma: mecanismo de tumorigénesis y papel como diana terapéutica.

TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.

By Grávalos Castro, Cristina. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of México. 2014 . 16(10):865-78. , Formato Vancouver: Benavides M, Abad A, Ales I, Carrato A, Díaz Rubio E, Gallego J et al. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer. Clin Transl Oncol. 2014 Oct;16(10):865-78.

Place Hold on TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.

Trastuzumab in small tumours and in elderly women.

By Ciruelos Gil, Eva María. Cancer treatment reviews, 2014 . 40(1):41-7. , Formato Vancouver: Albanell J, Ciruelos EM, Lluch A, Muñoz M, Rodríguez CA. Trastuzumab in small tumours and in elderly women. Cancer Treat Rev. 2014 Feb;40(1):41-7.

Place Hold on Trastuzumab in small tumours and in elderly women.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

By Ciruelos Gil, Eva María | Pascual Martínez, Pascual | Arroyo Vozmediano, María Luisa | Blanco Guerrero, Marta | Manso Sánchez, Luis | Parrilla Rubio, Lucía | Muñoz, César | Vega Alonso, Estela | Calderón, Monica Jackelin | Sancho, Blanca | Cortés-Funes Castro, Hernán. The Breast : official journal of the European Society of Mastology, 2014 . 23(3):201-8. , Formato Vancouver: Ciruelos E, Pascual T, Arroyo Vozmediano ML, Blanco M, Manso L, Parrilla L et al. The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer. Breast. 2014 Jun;23(3):201-8.

Place Hold on The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.

By Castellano, Daniel. Cancer chemotherapy and pharmacology, 2014 . 73(6):1095-107. , Formato Vancouver: García Del Muro X, Gallardo E, García Carbonero I, Laínez N, José Méndez M, Maroto P et al. Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma. Cancer Chemother Pharmacol. 2014 Jun;73(6):1095-107.

Place Hold on Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.

Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces.

By Ávila Martínez, Régulo José | Bartolomé Villar, Adela | Meneses Pardo, José Carlos | Gámez García, Pablo | Ponce Aix, Santiago | Zuluaga Bedoya, Mauricio. Cirugía española, 2013 . 91(10):625-32. , Formato Vancouver: Meneses JC, Avila Martínez RJ, Ponce S, Zuluaga M, Bartolomé A, Gámez P. Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces. Cir Esp. 2013 Dec;91(10):625-32.

Place Hold on Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces.